This Order adds a further group of cathinone derivatives (including Naphthylpyrovalerone, commonly known as Naphyrone) to Part 2 of Schedule 2 to the Misuse of Drugs Act 1971 which specifies drugs which are subject to control as Class B drugs under that Act. The ACMD report, “Consideration of the naphthylpyrovalerone analogues and related compounds” ostensibly provides the rationale.

Adds 4-Methylmethcathinone (Mephedrone) as a Class B substance, along with countable inifinity of cathinone analogues. The ACMD report, “Consideration of the cathinones” is well worth reading.

Adds a raft of new substances to the MDA 1971. This explanatory memorandum may be helpful.

The Drugs Act 2005 was put into force in several stages. The section outlawing Psilocin containing fungus came into force 18 July 2005 via S.I. 2005/1650.

This brings into force those provisions of the MDA 1971 which are not already in force, with effect from 1 Jul 1973.

This brings into force Sections 1, 32, 35, 37, 38, 40 of and Schedule 1 to the MDA 1971, with effect from 1 Feb 1972.

The MDA 1971 was put into force in two stages: 1 Feb 1972 via S.I. 1971/2120; and on 1 Jul 1973 via S.I. 1972/795.